Geneos Wealth Management’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13
Closed -$674 2895
2024
Q3
$674 Hold
13
﹤0.01% 2514
2024
Q2
$671 Hold
13
﹤0.01% 2024
2024
Q1
$866 Hold
13
﹤0.01% 2054
2023
Q4
$641 Hold
13
﹤0.01% 2066
2023
Q3
$723 Hold
13
﹤0.01% 2067
2023
Q2
$555 Hold
13
﹤0.01% 2064
2023
Q1
$632 Hold
13
﹤0.01% 2031
2022
Q4
$764 Sell
13
-33
-72% -$2.55K ﹤0.01% 1994
2022
Q3
$3K Sell
46
-42
-48% -$3.56K ﹤0.01% 1771
2022
Q2
$6K Hold
88
﹤0.01% 2123
2022
Q1
$13K Hold
88
﹤0.01% 1964
2021
Q4
$14K Hold
88
﹤0.01% 2041
2021
Q3
$20K Hold
88
﹤0.01% 1908
2021
Q2
$26K Hold
88
﹤0.01% 1774
2021
Q1
$28K Hold
88
﹤0.01% 1901
2020
Q4
$30K Hold
88
﹤0.01% 1695
2020
Q3
$11K Hold
88
﹤0.01% 1906
2020
Q2
$11K Hold
88
﹤0.01% 1867
2020
Q1
$9K Hold
88
﹤0.01% 1848
2019
Q4
$13K Buy
88
+13
+17% +$2.35K ﹤0.01% 1866
2019
Q3
$16K Buy
+75
New +$19.9K ﹤0.01% 1700

Other funds holding CNBS

Geneos Wealth Management's CNBS Position: Q4 2024 in Review

Geneos Wealth Management sold out of Amplify Seymour Cannabis ETF (CNBS) in Q4 2024, closing a stake of 13 shares — an estimated $674 sold.

Geneos Wealth Management first reported a position in CNBS in Q3 2019 and held it in 21 quarters. The position peaked at $30K in Q4 2020. 27 funds tracked by Wall St. Rank hold CNBS as of Q4 2024.

  • Geneos Wealth Management reported no remaining Amplify Seymour Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 13 Amplify Seymour Cannabis ETF shares in Q4 2024, an estimated $674.
  • Geneos Wealth Management first reported a position in Amplify Seymour Cannabis ETF in Q3 2019 and held it in 21 quarters.
  • Geneos Wealth Management's Amplify Seymour Cannabis ETF position peaked at $30K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.